强化与标准血压控制对脑白质病变的相关性研究
该研究为多中心随机临床试验的子研究,纳入50岁以上无糖尿病或卒中史的高血压患者,随机分为收缩压目标<120 mm Hg的强化治疗组(n=355)和<140 mm Hg的标准治疗组(n=315)。基线MRI 670例,随访4年完成449例。结果显示强化组脑白质病变体积增加较小,但全脑体积下降更明显,差异均较小。
要点
- 强化组脑白质病变体积增加0.92 cm³,标准组增加1.45 cm³,组间差异-0.54 cm³。
- 强化组全脑体积下降30.6 cm³,标准组下降26.9 cm³,组间差异-3.7 cm³。
- 强化降压与脑白质病变体积增加较小相关,但全脑体积下降更明显,差异均较小。
核心结论
- 在高血压成人中,收缩压目标<120 mm Hg与<140 mm Hg相比,与脑白质病变体积增加较小及全脑体积下降更明显显著相关,但差异均较小。
研究设计与样本
- 多中心随机临床试验的子研究,在美国27个中心进行,纳入50岁以上无糖尿病或卒中史的高血压成人。
- 随机化于2010年11月8日开始,因主要结局(心血管事件复合终点)和全因死亡获益,总体试验于2015年8月20日提前终止。
- 基线脑MRI subset n=670,4年随访MRI n=449;最终随访日期2016年7月1日。
- 参与者随机分为收缩压目标<120 mm Hg(强化治疗,n=355)或<140 mm Hg(标准治疗,n=315)。
主要发现
- 670例基线MRI参与者平均年龄67.3岁(SD 8.2),女性40.4%;449例(67.0%)完成随访MRI,随机化后中位时间3.97年,中位干预期3.40年。
- 强化组脑白质病变体积从4.57增至5.49 cm³(差值0.92 cm³ [95% CI 0.69至1.14]),标准组从4.40增至5.85 cm³(差值1.45 cm³ [95% CI 1.21至1.70]),组间变化差异-0.54 cm³(95% CI -0.87至-0.20)。
- 强化组全脑体积从1134.5降至1104.0 cm³(差值-30.6 cm³ [95% CI -32.3至-28.8]),标准组从1134.0降至1107.1 cm³(差值-26.9 cm³ [95% CI 24.8至28.8]),组间变化差异-3.7 cm³(95% CI -6.3至-1.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The effect of intensive blood pressure lowering on brain health remains uncertain. OBJECTIVE: To evaluate the association of intensive blood pressure treatment with cerebral white matter lesion and brain volumes. DESIGN, SETTING, AND PARTICIPANTS: A substudy of a multicenter randomized clinical trial of hypertensive adults 50 years or older without a history of diabetes or stroke at 27 sites in the United States. Randomization began on November 8, 2010. The overall trial was stopped early because of benefit for its primary outcome (a composite of cardiovascular events) and all-cause mortality on August 20, 2015. Brain magnetic resonance imaging (MRI) was performed on a subset of participants at baseline (n = 670) and at 4 years of follow-up (n = 449); final follow-up date was July 1, 2016. INTERVENTIONS: Participants were randomized to a systolic blood pressure (SBP) goal of either less than 120 mm Hg (intensive treatment, n = 355) or less than 140 mm Hg (standard treatment, n = 315). MAIN OUTCOMES AND MEASURES: The primary outcome was change in total white matter lesion volume from baseline. Change in total brain volume was a secondary outcome. RESULTS: Among 670 recruited patients who had baseline MRI (mean age, 67.3 [SD, 8.2] years; 40.4% women), 449 (67.0%) completed the follow-up MRI at a median of 3.97 years after randomization, after a median intervention period of 3.40 years. In the intensive treatment group, based on a robust linear mixed model, mean white matter lesion volume increased from 4.57 to 5.49 cm3 (difference, 0.92 cm3 [95% CI, 0.69 to 1.14]) vs an increase from 4.40 to 5.85 cm3 (difference, 1.45 cm3 [95% CI, 1.21 to 1.70]) in the standard treatment group (between-group difference in change, -0.54 cm3 [95% CI, -0.87 to -0.20]). Mean total brain volume decreased from 1134.5 to 1104.0 cm3 (difference, -30.6 cm3 [95% CI, -32.3 to -28.8]) in the intensive treatment group vs a decrease from 1134.0 to 1107.1 cm3 (difference, -26.9 cm3 [95% CI, 24.8 to 28.8]) in the standard treatment group (between-group difference in change, -3.7 cm3 [95% CI, -6.3 to -1.1]). CONCLUSIONS AND RELEVANCE: Among hypertensive adults, targeting an SBP of less than 120 mm Hg, compared with less than 140 mm Hg, was significantly associated with a smaller increase in cerebral white matter lesion volume and a greater decrease in total brain volume, although the differences were small. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01206062.
引用
- Nasrallah IM, Pajewski NM, Auchus AP, et al. Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. JAMA. 2019. PMID: 31408137. doi:10.1001/jama.2019.10551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。